Crescent Biopharma earnings beat by $0.04, revenue topped estimates — See source for full details.
$CBIO
Price history, market instrument context, member research, and related headlines in one place.
CBIO key statistics
Crescent Biopharma, Inc. (CBIO) is a stock instrument quoted on NasdaqCM in USD. The most recently published price is $12.48, down $0.10 (0.79%) from the previous close of $12.58. It has traded between $12.32 and $13.17 in the latest session. Over the past year it has ranged from $8.72 to $27.41, leaving it in the lower quarter of its 52-week range (20%). Reported volume for the session was 295.9K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation